High Court Won't Block Puerto Rico's Control Of Drug Prices

Law360, New York (October 7, 2013, 7:08 PM EDT) -- The U.S. Supreme Court on Monday declined to consider a Novartis Pharmaceuticals Corp. petition objecting to Puerto Rico's regulation of drug prices charged to wholesalers, leaving intact a lower court's finding that the oversight doesn't usurp Congress' power over interstate commerce.

As is customary, the high court offered no explanation for refusing to review the case, which centered on the so-called dormant Commerce Clause, an implied ban on regulation of interstate trade by states or territories that derives from the explicit power over such activity that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.